Rocket Fuel Inc. (FUEL) Jumps 7.48% on January 11

Equities Staff |

Rocket Fuel Inc. (FUEL) was among the biggest gainers on the Russell 2000 for Monday January 11 as the stock popped 7.48% to $3.45, representing a gain of $0.24 per share. Some 855,029 shares traded hands on 3,227 trades, compared with an average daily volume of 395,331 shares out of a total float of 43.02 million. The stock opened at $3.20 and traded with an intraday range of $3.60 to $3.11.

After today's gains, Rocket Fuel Inc. reached a market cap of $148.43 million. Rocket Fuel Inc. has had a trading range between $15.69 and $2.80 over the last year, and it had a 50-day SMA of $3.60 and a 200-day SMA of $6.36.

Rocket Fuel Inc is a technology company that has developed an Artificial Intelligence and Big Data-driven predictive modeling and automated decision-making platform.

Rocket Fuel Inc. is based out of Redwood City, CA and has some 1,123 employees. Its CEO is E. Randolph Wootton.

For a complete fundamental analysis analysis of Rocket Fuel Inc., check out’s Stock Valuation Analysis report for FUEL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…